Venture Capital: Life Beyond Academia

Venture capital is one of the primary funding sources for startup companies. If you are interested in entrepreneurship, come listen to Dr. Naeve talk about VC as a career option and the criteria used at Amgen Ventures for selecting companies to fund.

Dr. Naeve joined Amgen in 2005 and is the Managing Director of Amgen Ventures where she directs the fund's investment in biotechnology companies focused on discovering and developing human therapeutics. From 2002 to 2005, Dr. Naeve was director of Corporate Development at X-Ceptor Therapeutics which was acquired by Exelixis. Prior to this she was director of Business Development at Aurora Biosciences where she led transactions for the ion channel technology business unit and managed the collaborations with Pfizer, Merck, Lilly and Bristol Myers-Squibb. Dr. Naeve holds a Ph.D. in Pathology from University of Southern California and completed a post-doctoral fellowship at the California Institute of Technology.